These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 19237014

  • 1. Simvastatin inhibits sPLA2 IIa expression in aorta and myocardium.
    Wei-hua L, Chang-qing S, Qiang X, Rong W, Kai-min L.
    Arch Med Res; 2009 Feb; 40(2):67-72. PubMed ID: 19237014
    [Abstract] [Full Text] [Related]

  • 2. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z, Yang YJ, Qin XW, Ruan YM, Chen X, Meng L, Zhang HD.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 28; 86(44):3146-50. PubMed ID: 17313769
    [Abstract] [Full Text] [Related]

  • 3. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E, Gautier T, Rosengren B, Dikkers A, Behrendt M, Grass DS, Rader DJ, Tietge UJ.
    Arterioscler Thromb Vasc Biol; 2013 Dec 28; 33(12):2707-14. PubMed ID: 24115030
    [Abstract] [Full Text] [Related]

  • 4. [Effect of dachaihutang on expression of carnitine patmitoryl transferase-1 in vascular smooth muscle layer of atherosclerotic rabbits].
    Xuan L, Li X, Sheng X, Xu M, Che X.
    Zhongguo Zhong Yao Za Zhi; 2009 Sep 28; 34(17):2232-5. PubMed ID: 19943493
    [Abstract] [Full Text] [Related]

  • 5. Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice.
    Fraser H, Hislop C, Christie RM, Rick HL, Reidy CA, Chouinard ML, Eacho PI, Gould KE, Trias J.
    J Cardiovasc Pharmacol; 2009 Jan 28; 53(1):60-5. PubMed ID: 19129734
    [Abstract] [Full Text] [Related]

  • 6. Diabetes mellitus downregulates expression of connexin43 in rat aortic medial smooth muscle cells and can be reversed by simvastatin and losartan therapy.
    Sheu JJ, Tsai TH, Chang LT, Chiang CH, Youssef AA, Sun CK, Chang NK, Yip HK.
    Chang Gung Med J; 2008 Jan 28; 31(2):136-44. PubMed ID: 18567413
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
    Luchtefeld M, Bandlow N, Tietge UJ, Grote K, Pfeilschifter J, Kaszkin M, Beck S, Drexler H, Schieffer B.
    Atherosclerosis; 2007 Sep 28; 194(1):62-70. PubMed ID: 17069818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atherosclerosis.
    Nachtigal P, Kopecky M, Solichova D, Zdansky P, Semecky V.
    J Pharm Pharmacol; 2005 Feb 28; 57(2):197-203. PubMed ID: 15720783
    [Abstract] [Full Text] [Related]

  • 11. Crucial role of group IIA phospholipase A2 in pancreatitis-associated adrenal injury in acute necrotizing pancreatitis.
    Xu S, Chen C, Wang WX, Huang SR, Yu J, Chen XY.
    Pathol Res Pract; 2010 Feb 15; 206(2):73-82. PubMed ID: 19362431
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparative study of efficacy of tibolone and simvastatin on atherosclerosis in ovariectomized cholesterol-fed rabbits.
    Cui Y, Zhao D, Liu H, Ning Z, Yang J, Qing X, Yu S, Wu C.
    Maturitas; 2005 Apr 11; 50(4):337-43. PubMed ID: 15780535
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. sPLA2-IIA Augments Oxidized LDL-Induced MCP-1 Expression in Vitro Through Activation of Akt.
    Guo Y, Li B, Xu X, Wu R, Li W.
    Cell Physiol Biochem; 2015 Apr 11; 37(4):1345-54. PubMed ID: 26488172
    [Abstract] [Full Text] [Related]

  • 17. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells.
    Jaulmes A, Janvier B, Andreani M, Raymondjean M.
    Arterioscler Thromb Vasc Biol; 2005 Jun 11; 25(6):1161-7. PubMed ID: 15802623
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.
    Ravaux L, Denoyelle C, Monne C, Limon I, Raymondjean M, El Hadri K.
    Mol Cell Biol; 2007 Dec 11; 27(23):8374-87. PubMed ID: 17908795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.